Parabolic Drugs in News


Parabolic Drugs receives Certificate of Suitability for Cefixime molecule from EU
Parabolic Drugs 9M FY11 net profit up 65.6% to Rs. 37.30 Crores,Sales up 24.4% to Rs. 466.04 Crores(February 2nd,2011)
Parabolic Drugs Completes first phase of Expansion


Parabolic Drugs Q2FY11 Net Profit up 163.65% at Rs. 14.29 crore,Sales up 16.23% at Rs. 161.43 crore (November 8th,2010)
Parabolic Drugs Q1 profit rise by 36.29% (July 20th,2010)
PDL now gets EU-GMP accreditation(July 12th,2010)
PDL gets listed on NSE and BSE (July 1st,2010)
FY results for the year ended March 31st,2010
Barwala Research and Development centre inaugurated


WHO -GMP certificate for Cephalosporin facility(August 24th,2009)
ISO 14001 certification for PDL(August 6th,2010)

Quick Links

News Archives